Provides the latest information on new molecular entities, clinical trials, drug approvals, and post-approval studies of new drugs. Vol. 1. Part I: Introduction -- Part II: Oncology -- Vol. 2. Part II: Oncology -- Part III: Immune system -- Vol. 3. Part IV: Metabolic diseases -- Part V: Infectious diseases -- Vol. 4. Part VI: Emerging technologies and business opportunities -- Part VII: Global markets and national policy -- Part VIII: New opportunities in drug discovery and pipeline development -- Vol. 5. Part IX: Metabolic diseases -- Part X: Infectious diseases -- Part XI: Central nervous system -- Vol. 6. Part XI: Central nervous system -- Part XII: Opthalmologic -- Part XIII: Cardiology -- Vol. 7. Part XIII: Cardiology -- Part XIV: Genitourinary -- Part XV: Pain treatment -- Part XVI: Respiratory -- Part XVII: Gastrointestinal -- Part XVIII: Major issues in pharmaceutical R & D -- Part XIX: Global markets and national policy -- Part XX: Technological advances and business opportunities.
CITATION STYLE
Ritter, J. M. (2008). Wiley Handbook of Current and Emerging Drug Therapies. British Journal of Clinical Pharmacology, 65(3), 449–449. https://doi.org/10.1111/j.1365-2125.2007.03054.x
Mendeley helps you to discover research relevant for your work.